Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.
Journal: BMJ mental health
Year: February 06, 2024
Psychiatrist
5
No OPD information available
Schizophrenia
Bipolar Disorder (BPD)
Post-Traumatic Stress Disorder (PTSD)
Dagmar Koethe is a female healthcare provider who helps people with mental health conditions like schizophrenia, bipolar disorder, and post-traumatic stress disorder.
She uses special skills and treatments to assist her patients in managing their conditions and improving their overall well-being. Dagmar Koethe communicates with patients in a caring and understanding way, which helps them feel comfortable and trusting towards her.
To stay updated with the latest medical knowledge and research, Dagmar Koethe regularly attends conferences, reads medical journals, and collaborates with other healthcare professionals. This ensures that she can provide the best possible care to her patients.
Dagmar Koethe works closely with her colleagues and values teamwork when it comes to treating patients. By sharing knowledge and expertise with other medical professionals, she can offer comprehensive and effective care to those in need.
Through her work, Dagmar Koethe has positively impacted many patients' lives by helping them manage their mental health conditions and improve their quality of life. Her dedication and compassionate approach have made a significant difference in the well-being of those she treats.
One of Dagmar Koethe's notable publications is the study titled "Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers," published in BMJ mental health. She has also been involved in clinical trials, such as the investigation of the efficacy and safety of cannabidiol in acute, early-stage schizophrenic patients.
Overall, Dagmar Koethe is a caring and knowledgeable healthcare provider who is committed to helping individuals with mental health conditions lead healthier and happier lives.
Journal: BMJ mental health
Year: February 06, 2024
Enrollment Status: Terminated
Published: December 27, 2024
Intervention Type: Drug
Study Drug:
Study Phase: Phase 2
Dr. Koethe is an amazing Psychiatrist who truly cares about her patients. She listens attentively and provides great support. Highly recommend!
I have been seeing Dr. Koethe for a while now and she has helped me immensely. Her expertise and compassion make her an outstanding Psychiatrist.
Dr. Koethe is a wonderful Psychiatrist who is very knowledgeable and understanding. I feel comfortable discussing my concerns with her.
I am grateful for Dr. Koethe's guidance and expertise as my Psychiatrist. She has made a positive impact on my mental health journey.
Dr. Koethe is a top-notch Psychiatrist who goes above and beyond for her patients. I appreciate her dedication and support.
I highly recommend Dr. Koethe as a Psychiatrist. She is kind, understanding, and truly cares about her patients' well-being.
Dr. Koethe is an exceptional Psychiatrist who is very professional and compassionate. I feel fortunate to have her as my doctor.
Dr. Koethe is a fantastic Psychiatrist who has helped me navigate through challenging times. Her expertise and empathy are truly commendable.
I am so grateful for Dr. Koethe's support and guidance as my Psychiatrist. She is a true professional who genuinely cares about her patients.